KRAS G12C inhibitor 18

Modify Date: 2024-01-09 19:01:44

KRAS G12C inhibitor 18 Structure
KRAS G12C inhibitor 18 structure
Common Name KRAS G12C inhibitor 18
CAS Number 2649788-45-2 Molecular Weight 510.97
Density N/A Boiling Point N/A
Molecular Formula C25H20ClFN4O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of KRAS G12C inhibitor 18


KRAS G12C inhibitor 18 is a potent and orally active KRAS G12C inhibitor. Anti-tumor activities[1].

 Names

Name KRAS G12C inhibitor 18

 KRAS G12C inhibitor 18 Biological Activity

Description KRAS G12C inhibitor 18 is a potent and orally active KRAS G12C inhibitor. Anti-tumor activities[1].
Related Catalog
Target

KRas G12C

In Vitro KRAS G12C inhibitor 18 (compound 34) inhibits the growth of many KRas G12C mutant tumor cell lines (such as H358, SW1436, MiaPaca-2 cells, etc.)[1].
In Vivo KRAS G12C inhibitor 18 exhibits a dose dependent inhibiton of pERK and active KRas after a single dose treatment from 12.5 to 100 mg/kg at 8 hours[1]. KRAS G12C inhibitor 18 (30 mg/kg; p.o.; twice daily) exhibits anti-tumor growth activity in lung cancer H358 xenograft mouse model[1].
References

[1]. Serge Louis Boulet, et al. Kras g12c inhibitors. WO2021118877A1.

 Chemical & Physical Properties

Molecular Formula C25H20ClFN4O3S
Molecular Weight 510.97